51ÔÚÏß

Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
Return to PRWeb homepage
  • News
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • 51ÔÚÏß
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • 51ÔÚÏß PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • RSS
  • 51ÔÚÏß
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù
    • Heavy Industry & Manufacturing
    • °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • RSS
  • RSS
  • RSS

Quantumtronix Advances Precision Nutrition With Patent-Pending 'Multi-Target Cellular Delivery Network' as Carno Lux Sells Out in Record 60 Days


News provided by

Quantumtronix

Apr 23, 2026, 19:08 ET

Share this article

Share toX

Share this article

Share toX


Powered by a proprietary bio-electrical mineral matrix and a 5-component synergistic system, Carno Lux overcomes biological barriers to support precision delivery of nutrients to the intracellular environment.

MARKHAM, ON, April 23, 2026 /PRNewswire-PRWeb/ -- Quantumtronix Inc., a pioneer in integrated cellular engineering, today announced that the inaugural production run of Carno Lux, its flagship cellular-targeting supplement, sold out within 60 days of commercial launch.

The rapid sell-out marks a significant milestone for the company's bestn™ philosophy of Signal-Substance Synchronization — a proprietary framework that unites bio-energetic wearable technology(U.S. Provisional Patent Application No. 63/952,660) with advanced molecular nutrition. Carno Lux is built on Quantumtronix's proprietary High-Temperature Calcined Alkaline Mineral foundation, upon which the company's patent-pending 5-component Multi-Target Cellular Delivery Network (U.S. Provisional Patent Application No. 64/043,250) is engineered — creating a precision nutritional system designed to support natural protein integrity, combat oxidative stress, and support healthy cellular longevity.

This is not a treatment. This is not a cure. It is a precision-engineered system designed to maximize the body's own cellular resilience." — Philip Yu, Founder & CEO, Quantumtronix Inc

Post this

The Patent-Pending Innovation: A Synergistic Multi-Target Delivery Network (U.S. Provisional Patent Application No. 64/043,250)

Built upon Quantumtronix's proprietary alkaline mineral foundation, the patent-pending core of Carno Lux is a coordinated 5-component delivery network — each ingredient assigned a specific biological role, working in concert to support precision nutrient delivery at the cellular level. These compounds are sourced from rare specialty ingredients from U.S.-based S. and fine botanical extracts from France-based R.:

  • Target Navigation (Pterostilbene): Acting as a highly efficient lipophilic carrier, Pterostilbene helps water-soluble compounds bypass lipid barriers and supports blood-brain barrier (BBB) penetration, facilitating enhanced intracellular delivery.

  • Cellular Engine (L-Carnosine): The primary bioactive dipeptide. Once navigated into the cell, it helps support the body's natural defense against glycation — the bonding of sugars to proteins linked to cellular aging.

  • Bio-Shield (Microencapsulated SOD): A key endogenous antioxidant enzyme. Utilizing an advanced microencapsulation matrix, this Bio-Shield survives the harsh gastric environment to support the body's natural free radical defense at the optimal absorption site.

  • System Booster (Bioavailable Zinc): An essential structural cofactor. Zinc helps convert resting Apo-SOD enzymes into their fully active state, supporting the body's antioxidant capacity while also supporting natural DNA repair processes.

  • Logistics Network (Ginkgo Biloba Extract): Supports cerebral and peripheral microcirculation, helping to broaden bio-electrical conductivity pathways and ensuring all system components can rapidly reach their cellular destinations.

The Proprietary Foundation: 'Bio-Optical Cable' Effect and Alkaline Mineral Technology

Before the patent-pending delivery network can function, the body's internal environment must be optimized. This is Quantumtronix's foundational proprietary technology — independent of the patent filing — a High-Temperature Calcined Alkaline Mineral Salt matrix, processed at 1,200°C to eliminate impurities and stabilize the mineral structure. Unlike conventional salts, this calcination process produces a uniquely conductive mineral compound that supports pH balance and mineral homeostasis.

Quantumtronix describes this as the "Bio-Optical Cable" effect: Quantumtronix's exclusive alkaline mineral foundation acts as a highly conductive internal medium — optimizing the body's bioelectrical environment so that the patent-pending 5-component delivery network above can operate at its full potential, perfectly synchronizing the Signal with the Substance. This proprietary calcined mineral compound is the foundational raw material of the Carno Lux formulation, available independently as Quantumtronix's ΑΦΩΠ Pure Mineral Salt

What's Next: Zapfizz 1250 and Global Kickstarter Campaign

Building on the commercial validation of Carno Lux, Quantumtronix is in final performance testing for Zapfizz 1250 — a next-generation alkaline electrolyte beverage designed for on-the-go cellular hydration and bioelectrical conductivity support. Formulation patents for Zapfizz 1250 are currently in preparation. The global Kickstarter campaign is expected to launch in the coming months, offering early backers exclusive access to the complete bestn™ hardware-and-formulation bundle.

Statement from Philip Yu, Founder & CEO

"Harvard Medical School Professor of Genetics Dr. David Sinclair has long argued that aging is not an inevitability — it is a disease. We agree. And in an era where the scientific community is finally treating aging as a root biological condition, we asked ourselves a harder question: rather than waiting to treat its consequences, how do we address it at the source?

The answer begins at the Hayflick Limit. Science has established that normal human cells divide approximately 40 to 60 times before reaching their replicative boundary. At this threshold, cells do not simply die — they enter senescence. Researchers now call them 'zombie cells': cells that stop functioning yet refuse to die, instead releasing a chronic inflammatory cocktail known as SASP — Senescence-Associated Secretory Phenotype — that poisons surrounding healthy tissue and has been linked to age-related health decline. Research suggests even a small accumulation of senescent cells can initiate this degenerative process.

The scientific community's current response is senolytics — molecules designed to selectively destroy zombie cells. We took a different path. Our belief is that the more powerful intervention happens earlier: at the stage where cellular balance matters most. That is the philosophy behind Carno Lux and the bestn™ framework — Bio-Shield, Engine, System Booster, Target Navigation, Network.

This is not a treatment. This is not a cure. It is a precision-engineered system designed to maximize the body's own cellular resilience — to support the self-renewal capacity that keeps healthy cells healthy, and to restore the biological balance from which recovery becomes possible."

— Philip Yu, Founder & CEO, Quantumtronix Inc.

About Quantumtronix Inc.

Headquartered in Markham, Ontario, Quantumtronix Inc. develops integrated wellness platforms that harmonize wearable energy-harvesting hardware with advanced molecular nutrition to support human longevity and performance. northernsci.com | quantumtronix.net

Media Contact

Philip Yu, Founder & CEO — Quantumtronix Inc.

Phone: +1 365-391-0099

Email: LAB(at)NORTHERNSCI(dot)COM

Web: northernsci.com | quantumtronix.net

Legal Disclaimer: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Media Contact

Philip Yu, Quantumtronix, 1 3653910099 0, [email protected], quantumtronix.net

Philip Yu, Quantumtronix Inc, 1 3653910099 0, [email protected], quantumtronix.net

SOURCE Quantumtronix

Modal title

Carno Lux Original — the inaugural Health Canada NPN-licensed release by Quantumtronix Inc. Sold out in record 60 days. Photo courtesy of Quantumtronix Inc
Carno Lux Original — the inaugural Health Canada NPN-licensed release by Quantumtronix Inc. Sold out in record 60 days. Photo courtesy of Quantumtronix Inc
USPTO Patent Application No. 64/043,250 confirmed for Quantumtronix's B.E.S.T.N Cellular Delivery Network — the patent-pending core of Carno Lux. Photo courtesy of Quantumtronix Inc
USPTO Patent Application No. 64/043,250 confirmed for Quantumtronix's B.E.S.T.N Cellular Delivery Network — the patent-pending core of Carno Lux. Photo courtesy of Quantumtronix Inc
Quantumtronix's proprietary 1,200°C Calcined Alkaline Mineral Salt — the bio-electrical foundation of the Carno Lux bestn™ ecosystem. Photo courtesy of Quantumtronix Inc
Quantumtronix's proprietary 1,200°C Calcined Alkaline Mineral Salt — the bio-electrical foundation of the Carno Lux bestn™ ecosystem. Photo courtesy of Quantumtronix Inc
Carno Lux
Carno Lux
bestn™ ecosystem by Quantumtronix Inc. — five operational layers, three patent-backed pillars. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250. Photo courtesy of Quantumtronix Inc
bestn™ ecosystem by Quantumtronix Inc. — five operational layers, three patent-backed pillars. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250. Photo courtesy of Quantumtronix Inc
Philip Yu, Founder & CEO of Quantumtronix Inc. — pioneer in integrated cellular engineering and creator of the bestn™ 5-Core Cellular Delivery ecosystem. Photo courtesy of Quantumtronix In
Philip Yu, Founder & CEO of Quantumtronix Inc. — pioneer in integrated cellular engineering and creator of the bestn™ 5-Core Cellular Delivery ecosystem. Photo courtesy of Quantumtronix In
bestn™ by Quantumtronix — designed to support cellular balance at the Hayflick Limit, before senescent cell cascade begins. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250
bestn™ by Quantumtronix — designed to support cellular balance at the Hayflick Limit, before senescent cell cascade begins. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250
bestn™ by Quantumtronix — designed to support cellular balance at the Hayflick Limit, before senescent cell cascade begins. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250
bestn™ by Quantumtronix — designed to support cellular balance at the Hayflick Limit, before senescent cell cascade begins. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250
Carno Lux Original — the inaugural Health Canada NPN-licensed release by Quantumtronix Inc. Sold out in record 60 days. Photo courtesy of Quantumtronix Inc USPTO Patent Application No. 64/043,250 confirmed for Quantumtronix's B.E.S.T.N Cellular Delivery Network — the patent-pending core of Carno Lux. Photo courtesy of Quantumtronix Inc Quantumtronix's proprietary 1,200°C Calcined Alkaline Mineral Salt — the bio-electrical foundation of the Carno Lux bestn™ ecosystem. Photo courtesy of Quantumtronix Inc Carno Lux bestn™ ecosystem by Quantumtronix Inc. — five operational layers, three patent-backed pillars. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250. Photo courtesy of Quantumtronix Inc Philip Yu, Founder & CEO of Quantumtronix Inc. — pioneer in integrated cellular engineering and creator of the bestn™ 5-Core Cellular Delivery ecosystem. Photo courtesy of Quantumtronix In bestn™ by Quantumtronix — designed to support cellular balance at the Hayflick Limit, before senescent cell cascade begins. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250 bestn™ by Quantumtronix — designed to support cellular balance at the Hayflick Limit, before senescent cell cascade begins. U.S. Patent Apps. No. 63/952,660 & No. 64/043,250

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact 51ÔÚÏß

Products

My Services
  • All News Releases
51ÔÚÏß Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025  US Inc.